Walleye Capital’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $636K | Buy |
71,871
+71,449
| +16,931% | +$632K | ﹤0.01% | 989 |
|
|
2025
Q1 | $3.3K | Buy |
+422
| New | +$3.3K | ﹤0.01% | 1759 |
|
|
2024
Q3 | – | Sell |
-766
| Closed | -$10.8K | – | 2486 |
|
|
2024
Q2 | $10.8K | Sell |
766
-9,019
| -92% | -$127K | ﹤0.01% | 2355 |
|
|
2024
Q1 | $165K | Buy |
+9,785
| New | +$165K | ﹤0.01% | 1872 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2192 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2276 |
|
|
2019
Q4 | – | Sell |
-30,758
| Closed | -$128K | – | 662 |
|
|
2019
Q3 | $128K | Buy |
+30,758
| New | +$128K | 0.01% | 257 |
|